Radiation therapy for active thyroid eye disease
Treatments studied
Part of Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether targeted radiation to the eyes can help reduce the inflammation and symptoms of Graves' eye disease (also called thyroid eye disease). It is for people who have had eye symptoms for less than a year and whose eyes are still actively inflamed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Graves' disease, which is diagnosed by having an overactive thyroid and certain antibodies in your blood.
- Your eye problems from Graves' disease should have started within the last year.
- Your eye disease must be active, meaning it is causing noticeable inflammation and symptoms.
- You must be between 35 and 75 years old.
- You cannot have other serious eye conditions like glaucoma, diabetes-related eye damage, or previous eye surgery.
- You must be able to avoid pregnancy during the trial if you are a woman who can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a shorter course of radiation (1 week) works as well as a standard longer course (2 weeks) for treating active thyroid eye disease that did not improve enough with steroid medicine. It may be an option if you still have eye symptoms after steroid treatment.
This Phase 2 study compares sirolimus versus corticosteroids to treat active thyroid eye disease. It aims to see which treatment works better to calm eye inflammation and improve symptoms, without needing urgent eye surgery.
This study aims to build a model that helps doctors predict how thyroid eye disease (TAO) will progress, specifically for patients with moderate to severe symptoms. If you have had TAO and meet the activity criteria, your participation could lead to better personalized care.
This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.
This trial tests whether atorvastatin, a cholesterol-lowering drug, can improve symptoms of thyroid eye disease (Graves' orbitopathy). It is for people with moderate-to-severe, active eye disease who have not recently used steroids or other treatments for it.
This study tests whether high-dose steroid pulses (given through a vein) can help people with moderate to severe Graves' eye disease that is still active. It is for people who have not yet been treated with steroids and whose eye problems began within the past year.
Hear when a new Thyroid Associated Ophthalmopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.